These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2530253)

  • 1. Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients.
    Boyd AS; Menter A
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):985-91. PubMed ID: 2530253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrodermic psoriasis: epidemiological clinical and therapeutic features about 60 cases].
    Hawilo A; Zaraa I; Benmously R; Mebazaa A; El Euch D; Mokni M; Ben Osman A
    Tunis Med; 2011 Nov; 89(11):841-7. PubMed ID: 22179920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of successful treatment, by a photochemotherapy method, of psoriatic erythroderma due to total ultraviolet irradiation].
    Skripkin IuK; Korotkiĭ NG; Butov IuS; Savkina AS; Biriukov AV
    Vestn Dermatol Venerol; 1982 Sep; (9):40-2. PubMed ID: 6217691
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab.
    Richetta AG; Maiani E; Carlomagno V; Carboni V; Mattozzi C; Giancristoforo S; Calvieri S
    Dermatol Ther; 2009 Nov; 22 Suppl 1():S16-8. PubMed ID: 19891686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of carbamazepine in a HIV-1-positive patient with psoriatic erythroderma.
    Smith KJ; Decker C; Yeager J; Skelton HG; Baskin S
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 2):851-4. PubMed ID: 9366851
    [No Abstract]   [Full Text] [Related]  

  • 6. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
    Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
    Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment.
    Kop EN; Körver JE; Van Ruysevelt D; De Jong EM; Van der Valk PG; Van de Kerkhof PC
    J Dermatolog Treat; 2009; 20(1):67-9. PubMed ID: 18651300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.
    Rongioletti F; Borenstein M; Kirsner R; Kerdel F
    J Dermatolog Treat; 2003 Dec; 14(4):222-5. PubMed ID: 14660268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis-induced postoperative cardiac failure.
    Jha PK; Das SR; Musleh GS; Lakshmanan S; Kingston TP; Deiraniya AK
    Ann Thorac Surg; 2005 Apr; 79(4):1390-1. PubMed ID: 15797087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.
    Campbell LS; Chevalier M; Levy RA; Rhodes A
    Pediatr Dermatol; 2012; 29(1):101-4. PubMed ID: 21995486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration.
    Mashima E; Sawada Y; Yamaguchi T; Yoshioka H; Ohmori S; Haruyama S; Okada E; Nakamura M
    Eur J Dermatol; 2018 Aug; 28(4):539-540. PubMed ID: 30325327
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
    Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
    J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
    Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythroderma in adults: a report of 80 cases.
    Rym BM; Mourad M; Bechir Z; Dalenda E; Faika C; Iadh AM; Amel BO
    Int J Dermatol; 2005 Sep; 44(9):731-5. PubMed ID: 16135140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recalcitrant Erythrodermic Psoriasis Complicated by Septic Shock and Mycotic Aneurysm: A Call for Treatment Guidelines.
    J Drugs Dermatol; 2024 Aug; 23(8):680-682. PubMed ID: 39093644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroderma in the era of biological therapies.
    Zattra E; Belloni Fortina A; Peserico A; Alaibac M
    Eur J Dermatol; 2012; 22(2):167-71. PubMed ID: 22321651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail.
    Buggiani G; D'Erme AM; Krysenka A; Pescitelli L; Lotti T; Prignano F
    Dermatol Ther; 2012; 25(3):283-5. PubMed ID: 22913449
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
    Arbiser JL; Grossman K; Kaye E; Arndt KA
    Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate].
    Allegue Rodriguez F; Sendagorta Gomendio E; Freire Murgueytio P; Moreno Izquierdo R; Ledo Pozueta A
    Med Cutan Ibero Lat Am; 1988; 16(1):43-9. PubMed ID: 2967409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.